Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kovar

Showing results (721-730 of 949) with videos related to

Pageof 95
Sort By:
Infection and Immunity|April 12, 2017
Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussisKarolina Skopova, Barbora Tomalova, Ivan Kanchev, et al.
Journal of Applied Biomedicine|October 22, 2024
Olfactory event-related potentials (OERPs) and trigeminal event-related potentials (TERPs) in subjects after Covid-19 infection: single-center prospective studyRichard Holy, David Kalfert, Libor Vasina, et al.
Clinical Pharmacology and Therapeutics|March 31, 2025
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy ParticipantsNassr Nassr, Faiza Rharbaoui, Dietmar Weitz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2016
Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patientsVeronika Brynychova, Marie Ehrlichova, Viktor Hlavac, et al.
European Heart Journal|September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndromePh Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitorK M Verburg, J S Polakowski, P J Kovar, et al.
Frontiers in Endocrinology|November 3, 2018
The Effect of Hypoxia and Metformin on Fatty Acid Uptake, Storage, and Oxidation in L6 Differentiated MyotubesMartina Musutova, Moustafa Elkalaf, Natalie Klubickova, et al.
Vaccine|December 10, 2022
A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and WalesAimee Serisier, Sarah Beale, Yamina Boukari, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansionIrfan Baki Kilic, Petra Weberova, Derek VanDyke, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Novel sulfonate derivatives: potent antimitotic agentsS L Gwaltney, H M Imade, Q Li, et al.
Pageof 95

Showing results (721-730 of 949) with videos related to

Sort By:
Pageof 95
Infection and Immunity|April 12, 2017
Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussisKarolina Skopova, Barbora Tomalova, Ivan Kanchev, et al.
Journal of Applied Biomedicine|October 22, 2024
Olfactory event-related potentials (OERPs) and trigeminal event-related potentials (TERPs) in subjects after Covid-19 infection: single-center prospective studyRichard Holy, David Kalfert, Libor Vasina, et al.
Clinical Pharmacology and Therapeutics|March 31, 2025
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy ParticipantsNassr Nassr, Faiza Rharbaoui, Dietmar Weitz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 10, 2016
Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patientsVeronika Brynychova, Marie Ehrlichova, Viktor Hlavac, et al.
European Heart Journal|September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndromePh Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitorK M Verburg, J S Polakowski, P J Kovar, et al.
Frontiers in Endocrinology|November 3, 2018
The Effect of Hypoxia and Metformin on Fatty Acid Uptake, Storage, and Oxidation in L6 Differentiated MyotubesMartina Musutova, Moustafa Elkalaf, Natalie Klubickova, et al.
Vaccine|December 10, 2022
A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and WalesAimee Serisier, Sarah Beale, Yamina Boukari, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansionIrfan Baki Kilic, Petra Weberova, Derek VanDyke, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Novel sulfonate derivatives: potent antimitotic agentsS L Gwaltney, H M Imade, Q Li, et al.
Pageof 95